150 Participants Needed

MRI Study of Eating Behavior for Bulimia

JD
AR
RM
Overseen ByRiley Macks
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Icahn School of Medicine at Mount Sinai
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for treatment. This project aims to understand how predictions and value-based decisions about control may be abnormally influenced by eating in individuals with BN, thereby maintaining cycles of binge eating, purging, and restriction.

Do I need to stop taking my current medications to join the trial?

The trial excludes participants with ongoing medical treatment that may interfere with the study, so you might need to stop certain medications. It's best to discuss your specific medications with the trial team.

What data supports the effectiveness of the treatment Fasting state, Fed state, Magnetic Resonance Imaging, Lumakras, Vectibix for bulimia?

Research shows that brain imaging techniques like MRI can help understand the brain changes in bulimia, which might be useful in developing new treatments. However, there is no direct evidence supporting the effectiveness of Lumakras or Vectibix for bulimia, as these drugs are typically used for other conditions.12345

Is MRI safe for studying eating behavior in bulimia?

MRI is generally considered safe for studying brain activity and structure, as it is a non-invasive imaging technique that does not use radiation.12356

How does this MRI-based treatment for bulimia differ from other treatments?

This MRI-based treatment for bulimia is unique because it focuses on understanding and potentially altering brain activity related to eating behaviors, using imaging techniques to explore neural pathways involved in hunger, satiety, and reward systems. Unlike traditional treatments that may focus on behavioral therapy or medication, this approach aims to identify and address the underlying brain mechanisms contributing to bulimia.12457

Research Team

LA

Laura A Berner, Ph.D.

Principal Investigator

Mount Sinai Icahn School of Medicine

Eligibility Criteria

This trial is for right-handed, English-speaking females aged 18-45 with a BMI between 18.5 and under 30 who meet the criteria for bulimia nervosa. It's not suitable for those medically unstable, on ongoing treatment, doing shift work, pregnant or lactating, allergic to meal ingredients used in the study, or unable to undergo an fMRI.

Inclusion Criteria

Current BMI greater than or equal to 18.5kg/m2 but under 30kg/m2
Right-handed
I am female.
See 3 more

Exclusion Criteria

Shift work
Pregnancy, planned pregnancy, or lactation during the study period
Ongoing medical treatment, medical condition, or psychiatric disorder that may interfere with study variables or participation
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo fMRI scans after fasting and after a standardized meal to assess neural activation related to cognitive control in bulimia nervosa

2 days
2 visits (in-person)

Follow-up

Participants are monitored for changes in binge-eating, dietary restriction, and compensatory behaviors

6 months

Treatment Details

Interventions

  • Fasting state
  • Fed state
  • Magnetic Resonance Imaging
Trial OverviewThe study examines how eating affects decision-making and self-control in women with bulimia nervosa by comparing their brain activity before and after eating using MRI scans while they are in fasting and fed states.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Participants with Bulimia NervosaExperimental Treatment3 Interventions
Participants are randomly assigned (in even numbers across the two groups) to scan order: A. These participants are first scanned after 16 hours of fasting on one day, and are next scanned after a standardized meal on a second day. B. These participants are first scanned after a standardized meal on one day, and are next scanned after 16 hours of fasting on a second day.
Group II: Participants without Bulimia NervosaActive Control3 Interventions
Participants are randomly assigned (in even numbers across the two groups) to scan order: A. These participants are first scanned after 16 hours of fasting on one day, and are next scanned after a standardized meal on a second day. B. These participants are first scanned after a standardized meal on one day, and are next scanned after 16 hours of fasting on a second day.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials
933
Recruited
579,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

In a study involving 31 patients with bulimia nervosa (BN) and 28 healthy controls, BN patients showed increased gray matter volume in the left medial orbitofrontal cortex (mOFC), indicating structural brain changes associated with the disorder.
The study also found altered resting-state functional connectivity (rsFC) in BN patients, with increased connectivity between the mOFC and visual processing areas, which may relate to body image perception and eating behaviors, highlighting the mOFC's role in the neurobiology of BN.
Altered gray matter volume and functional connectivity in medial orbitofrontal cortex of bulimia nervosa patients: A combined VBM and FC study.Li, WH., Tang, LR., Wang, M., et al.[2022]
Women with bulimia nervosa exhibited reduced brain activation in response to food intake and anticipated food compared to healthy controls, suggesting a potential dysfunction in the brain's reward system.
This hypofunctioning may contribute to binge eating behaviors as individuals with bulimia nervosa might seek to compensate for a lack of reward from food.
Reward abnormalities among women with full and subthreshold bulimia nervosa: a functional magnetic resonance imaging study.Bohon, C., Stice, E.[2022]
Women with bulimia nervosa (BN) showed decreased white matter integrity, particularly in areas related to taste and reward processing, indicating potential disruptions in brain functionality associated with the disorder.
In contrast to control women, BN women did not exhibit a correlation between white matter integrity and anxiety traits, suggesting that altered white matter functionality may contribute to anxiety in bulimia nervosa.
White matter integrity is reduced in bulimia nervosa.Mettler, LN., Shott, ME., Pryor, T., et al.[2021]

References

Altered gray matter volume and functional connectivity in medial orbitofrontal cortex of bulimia nervosa patients: A combined VBM and FC study. [2022]
Reward abnormalities among women with full and subthreshold bulimia nervosa: a functional magnetic resonance imaging study. [2022]
White matter integrity is reduced in bulimia nervosa. [2021]
[Cognitive function in eating disorders]. [2015]
Test-retest reliability of functional MRI food receipt, anticipated receipt, and picture tasks. [2023]
Characteristics of white matter alterations along fibres in patients with bulimia nervosa: A combined voxelwise and tractography study. [2023]
Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study. [2008]